IL1B and cancer: Constitutive activation of NF-κB, the major pathway that regulates immune inflammatory responses [19] and produces pro-inflammatory cytokines, such as TNF-α, IL-1β, and IL-6 [15,20], leads to chronic inflammation, which promotes cancer [1,21,22].